Patients with COPD diagnosed in-hospital vs in a primary care setting tended to be older, men, and had a greater number of comorbidities.

WESTFIELD - The adage of “don’t let limitations confine you” is one that Irene Lansing embodies on a daily basis.

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...

The FDA has accepted for review the BLA for mepolizumab as an add-on maintenance treatment for eosinophilic COPD.

Higher dietary magnesium intake is associated with a reduced risk of frailty in patients with chronic obstructive pulmonary ...

British drug maker GSK plc (GSK, GSK.L) announced Monday that the U.S. Food and Drug Administration has accepted for review, data ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

Nearly 4 million patients with chronic obstructive pulmonary disease (COPD) or asthma die each year, mostly from severe acute ...